Trulieve Cannabis: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Trulieve Cannabis (OTC:TCNNF) reported its Q3 earnings, beating estimated earnings by 52.94% with an EPS of $-0.08 versus an estimate of $-0.17. However, revenue was down $25.59 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by a 1.43% drop in the share price the next day.
November 09, 2023 | 11:20 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Trulieve Cannabis beat Q3 earnings estimates but reported a decrease in revenue compared to the same period last year. Past performance shows a drop in share price following a beat on EPS.
While Trulieve Cannabis beat earnings estimates, the decrease in revenue compared to the same period last year could be a concern for investors. Additionally, past performance shows a drop in share price following a beat on EPS, which could potentially happen again.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100